ROCKVILLE, Md., Nov. 20, 2013 /PRNewswire/ -- OncoPlex Diagnostics a CAP-accredited, CLIA-certified cancer diagnostics laboratory providing clinical proteomics and genomics supporting personalized patient care announced the appointment of Dr. Jedd Levine to the position of Chief Medical Officer. Dr. Levine will report to the CEO, Jon Burrows, Ph.D., in the role. The appointment of Dr. Levine adds an increased level of clinical oncology expertise to OncoPlexDx.
(Logo: http://photos.prnewswire.com/prnh/20131022/PH00498LOGO )
“I am delighted that Jedd Levine has joined OncoPlex Diagnostics to lead our Medical and Clinical Affairs departments. His background and experience adds an expanded dimension to our senior management team as we accelerate the adoption of our clinical offerings,” said Jon Burrows, “Dr. Levine brings over 25 years of experience treating cancer patients in both community and academic oncology centers. We are pleased to have him on our leadership team as we continue to build our molecular testing menu.”
Jedd Levine, M.D., M.B.A. is Managing Director with JL Healthcare Consultants, LLC and has a faculty appointment in the Medical Oncology department at the Yale University School of Medicine. Dr. Levine has served as Managing Partner for Connecticut Oncology & Hematology, Chief Medical Officer at Egenix, an early-stage oncology development company, and as Clinical Assistant Professor on the Medical Oncology faculty at Stanford University School of Medicine. Dr. Levine is board certified in Internal Medicine and Medical Oncology.
Dr. Levine obtained his M.D. from Harvard Medical School, M.B.A. from Columbia Business School, and B.S. from Yale University.
About OncoPlex Diagnostics
OncoPlex Diagnostics (http://www.oncoplexdx.com/), is a CAP-accredited, CLIA-certified oncology diagnostics laboratory linking clinical proteomics and genomics supporting personalized patient care. Our company has an important single focus: providing the most comprehensive characterization of patients’ tumors from the same tumor cells. Our proprietary multiplexed method is one of the most sensitive and specific detection tools available in the clinical laboratory today.
SOURCE OncoPlex Diagnostics
Help employers find you! Check out all the jobs and post your resume.
